Skip to main content

Table 1 Characteristics of the study groups

From: A randomized controlled trial on the efficacy of carbohydrate-reduced or fat-reduced diets in patients attending a telemedically guided weight loss program

Characteristics1

DGE group (n = 100)2

LOGI group (n = 100)2

P value3

Men (n)

24

38

0.032

Age (y)

47 (10.8)

47 (10.3)

0.958

Current smoker (n)

43

44

0.887

Height (m)

1.7 (0.1)

1.7 (0.1)

0.153

Weight (kg)

98.8 (16.9)

100.3 (15.9)

0.526

Body Mass Index (kg/m2)

33.8 (4.8)

33.5 (3.9)

0.665

Fat mass (kg)

40.9 (11.6)

39.3(10.1)

0.314

Fat-free Mass (kg)

57.5 (10.4)

61.0 (12.2)

0.032

Waist circumference (cm)

108.1 (13.1)

109.9 (10.7)

0.277

Heart rate (beats/min)

70.5 (12.1)

69.5 (11.9)

0.537

Systolic blood pressure (mmHg)

128 (14)

126 (13)

0.408

Diastolic blood pressure (mmHg)

86 (8)

86 (8)

0.858

Triglycerides (mmol/l)

1.39 (0.65)

1.31 (0.56)

0.357

Total cholesterol (mmol/l)

5.54 (1.10)

5.50 (0.93)

0.805

LDL-cholesterol (mmol/l)

3.56 (0.91)

3.54 (0.80)

0.635

HDL-cholesterol (mmol/l)

1.46 (0.37)

1.49 (0.37)

0.612

Glucose (mmol/l)

5.62 (0.85)

5.68 (1.09)

0.650

Fructosamine (μmol/l)

284.2 (28.2)

286.1 (26.4)

0.633

HbA1c (%)

5.6 (0.5)

5.6 (0.5)

0.764

Proinsulin (pmol/L)

9.4 (8.9)

11.5 (14.4)

0.217

Adiponectin (μg/ml)

6.7 (3,7)

6.4 (3.5)

0.642

Metabolic syndrome (%)

54.0

45.0

0.203

Drug therapy (%)

   

   - Antihypertensive drugs

31.0

24.0

0.268

   - Lipid-lowering drugs

4.0

6.0

0.516

   - Antidiabetic drugs

1.0

4.0

0.174

  1. 1mean (standard deviation) and percentage, respectively; 2DGE group; high carbohydrate diet; LOGI group; low carbohydrate diet; 3unpaired t-test, or Chi-square test when appropriate.